Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids

Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids

Bibliographic Details
Main Authors:	Boichenko Alexander, Markov Vadim, Kong Hoan, Matveeva Anna, Loginova Lidia
Format:	Article
Language:	English
Published:	De Gruyter 2009-03-01
Series:	Open Chemistry
Subjects:	alendronate olpadronate, pamidronate dissociation constant micellar media effect
Online Access:	https://doi.org/10.2478/s11532-008-0099-z

Similar Items

Effect of Bisphosphonates on Function and Mobility Among Children With Osteogenesis Imperfecta: A Systematic Review
by: Christopher S. Constantino, et al.
Published: (2019-10-01)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Validated spectrophotometric methods for determination of Alendronate sodium in tablets through nucleophilic aromatic substitution reactions
by: Walash Mohamed I, et al.
Published: (2012-04-01)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

Therapy with pamidronate in children with osteogenesis imperfecta
by: Marginean O, et al.
Published: (2017-08-01)

Pamidronate “zebra lines”: A treatment timeline
by: Avgi Loizidou, BSc, MBChB, et al.
Published: (2017-12-01)

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
by: Mansour Salesi, et al.
Published: (2011-01-01)

Evaluation of Two Different Pamidronate Treatment Protocols in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2014-06-01)

Effect of pamidronate and calcium on implant osseointegration in ovariectomized rats
by: Mehrnoush Momeni, et al.
Published: (2016-09-01)

Effect of Pamidronate on Bone Pain in Patients with Bone Metastasis
by: Shahrbanoo Keihanian, et al.
Published: (2013-06-01)

Comparison of Calcitonin and Pamidronate Treatments in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2013-08-01)

Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Leila Bianchet Zanatta, et al.

Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome
by: Sami A. Sanjad, et al.
Published: (2018-05-01)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
by: Ji-Hee Yoon, et al.
Published: (2021-06-01)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
by: Se Won Lim, et al.
Published: (2016-03-01)

EFFECTS OF PAMIDRONATE ADMINISTRATION ON TOOTH ERUPTION AND MANDIBULAR GROWTH IN NEW BORN RATS
by: İbrahim Tuncer, et al.
Published: (2017-01-01)

Sternocostoclavicular Hyperostosis: Positive Clinical and Radiological Response on Pamidronate
by: Anne T. Leerling, et al.
Published: (2021-02-01)

Effect of Pamidronate on Hypercalcemia, BUN and Cr in Patients with Malignancy
by: Shahrbanoo Keyhanian, et al.
Published: (2016-05-01)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

Uso do pamidronato na síndrome SAPHO Pamidronate treatment in SAPHO syndrome
by: Luana Gerheim Machado, et al.
Published: (2005-12-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

The thermodynamic dissociation constant of naphazoline by the regression analysis of potentiometric data
by: Meloun Milan, et al.
Published: (2011-02-01)

Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity
by: C. S. Bhat, et al.
Published: (2019-07-01)

Esophageal ulcer and alendronate
by: Angelo Paulo Ferrari Junior, et al.

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

Thermodynamic dissociation constants of risedronate using spectrophotometric and potentiometric pH-titration
by: Meloun Milan, et al.
Published: (2012-04-01)

Pharmacokinetics of alendronate in a combined Alendronate/Vitamin D3 tablet in healthy volunteers using plasma and urine data
by: Chalitpon Na nakorn, et al.
Published: (2013-06-01)

The presence of pamidronate in bone cement affects serum biochemical markers in the rat
by: Matuszewski Łukasz, et al.
Published: (2014-06-01)

Important hypercalcemia due to subcutaneous fat necrosis treated with pamidronate in an infant with severe hypoxic-ischemic encephalopathy
by: Pasqua Anna Quitadamo, et al.
Published: (2016-08-01)

Important hypercalcemia due to subcutaneous fat necrosis treated with pamidronate in an infant with severe hypoxic-ischemic encephalopathy
by: Pasqua Anna Quitadamo, et al.
Published: (2016-08-01)

Cyclic pamidronate treatment for osteogenesis imperfecta: Report from a Brazilian reference center
by: Bruna Pinheiro, et al.
Published: (2019-04-01)

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients
by: Fabrizio Pin, et al.
Published: (2019-08-01)

Irrational use of alendronate sodium by the elderly
by: Camila Pereira Alvim, et al.
Published: (2020-11-01)

Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review
by: Veronica Mugarab Samedi, et al.
Published: (2014-11-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Experimental osteonecrosis: development of a model in rodents administered alendronate
by: Nicolau CONTE NETO, et al.

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)

Cannot write session to /tmp/vufind_sessions/sess_6jnlr6tvugk5lp4gsnt3diptes